Boostrix (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed) – New indication
October 7, 2022 - The FDA announced the approval of GSK’s Boostrix (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed), for immunization during the third trimester of pregnancy to prevent pertussis in infants younger than 2 months of age.
Top